Mr Jack Scanlan
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
As a third-year laboratory-based PhD candidate in the Mass Spectrometry and Proteomics Facility, I use mass spectrometry to improve our understanding of malignant ascites in ovarian cancer. My research focuses on identifying protein biomarkers and predictive signatures within this novel biofluid, with the aim of enabling personalised treatment strategies and improving clinical decision-making.
My work has been published in Science Advances and the Journal of Proteome Research, including a systematic review and experimental studies exploring proteomic predictors of therapeutic response in high-grade serous ovarian cancer. I am also interested in the broader applications of proteomics in precision medicine, including how these technologies can be translated into practice through evidence-based health policy.
| Date | Position | Institution name |
|---|---|---|
| 2024 - ongoing | Technical Officer | Adelaide University |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2026 - 2027 | The University of Sydney | Australia | Master of Health Policy and Planning |
| 2024 - 2027 | Adelaide University | Australia | Doctor of Philosophy |
| 2022 - 2022 | University of South Australia | Australia | Bachelor of Biomedical Research (Honours) |
| 2019 - 2021 | Flinders University | Australia | Bachelor of Medical Science |
| Date | Title | Institution name | Country |
|---|---|---|---|
| 2025 | Working with Children Check | Government of South Australia | - |
| Year | Citation |
|---|---|
| 2026 | Scanlan, J., Mittal, P., Lokman, N. A., Oehler, M. K., Hoffmann, P., & Klingler-Hoffmann, M. (2026). Toward Proteomic-Based Prediction of Ex Vivo Platinum Sensitivity in Ovarian Cancer Ascitic Cellular Aggregates: A Pilot Study. Journal of Proteome Research, 25(2), 828-841. |
| 2026 | Dorstyn, L., Lim, Y., Scanlan, J., McLennan, E., De Bellis, D., Katschner, M., . . . Kumar, S. (2026). Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice. Science Advances, 12(1), eaeb2571-1-eaeb2571-20. |
| 2026 | Scanlan, J., Mittal, P., Oehler, M. K., Hoffmann, P., & Hoffmann, M. K. (2026). Proteomic Studies That Predict Patients’ Responses to High-Grade Serous Ovarian Cancer Treatments: A Systematic Review. Journal of Proteome Research, 25(2), 1126-1138. |
| Year | Citation |
|---|---|
| 2026 | Scanlan, J., Mittal, P., Washington, J., Young, C., Oehler, M. K., Hoffmann, P., & Klingler-Hoffmann, M. (2026). Ascites-Driven Modulation of Cell Phenotypes and Proteomes: Implications for Cancer Progression. DOI |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2025 - 2025 | Member | UniSA Clinical and Health Sciences Academic Unit Board | University of South Australia | Australia |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2025 - ongoing | Member | Adelaide Protein Group | Adelaide Protein Group | Australia |
Connect With Me
External Profiles
